NCT00833417 2026-05-11A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell CarcinomaGenentech, Inc.Phase 2 Completed104 enrolled 13 charts
NCT06483555 2026-04-23PANGEAUNC Lineberger Comprehensive Cancer CenterPhase 1/2 Recruiting104 enrolled